196 related articles for article (PubMed ID: 19918332)
21. Columnar cell lesions: current classification and controversies.
Nasser SM
Semin Diagn Pathol; 2004 Feb; 21(1):18-24. PubMed ID: 15074555
[TBL] [Abstract][Full Text] [Related]
22. Angiogenesis in the progression of breast ductal proliferations.
Carpenter PM; Chen WP; Mendez A; McLaren CE; Su MY
Int J Surg Pathol; 2011 Jun; 19(3):335-41. PubMed ID: 19403546
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules.
Tremblay G; Deschênes J; Alpert L; Quenneville LA
Breast J; 2005; 11(5):326-32. PubMed ID: 16174153
[TBL] [Abstract][Full Text] [Related]
24. Pseudoangiomatous stromal hyperplasia (PASH) of the breast with foci of morphologic malignancy: a case of PASH with malignant transformation?
Nassar H; Elieff MP; Kronz JD; Argani P
Int J Surg Pathol; 2010 Dec; 18(6):564-9. PubMed ID: 18611932
[TBL] [Abstract][Full Text] [Related]
25. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients.
Collins LC; Achacoso NA; Nekhlyudov L; Fletcher SW; Haque R; Quesenberry CP; Alshak NS; Puligandla B; Brodsky GL; Schnitt SJ; Habel LA
Mod Pathol; 2007 Nov; 20(11):1149-55. PubMed ID: 17767135
[TBL] [Abstract][Full Text] [Related]
26. Are columnar cell lesions the earliest histologically detectable non-obligate precursor of breast cancer?
Turashvili G; Hayes M; Gilks B; Watson P; Aparicio S
Virchows Arch; 2008 Jun; 452(6):589-98. PubMed ID: 18437416
[TBL] [Abstract][Full Text] [Related]
27. Concurrent and independent genetic alterations in the stromal and epithelial cells of mammary carcinoma: implications for tumorigenesis.
Moinfar F; Man YG; Arnould L; Bratthauer GL; Ratschek M; Tavassoli FA
Cancer Res; 2000 May; 60(9):2562-6. PubMed ID: 10811140
[TBL] [Abstract][Full Text] [Related]
28. Impact of Epithelial-Stromal Interactions on Peritumoral Fibroblasts in Ductal Carcinoma in Situ.
Strell C; Paulsson J; Jin SB; Tobin NP; Mezheyeuski A; Roswall P; Mutgan C; Mitsios N; Johansson H; Wickberg SM; Svedlund J; Nilsson M; Hall P; Mulder J; Radisky DC; Pietras K; Bergh J; Lendahl U; Wärnberg F; Östman A
J Natl Cancer Inst; 2019 Sep; 111(9):983-995. PubMed ID: 30816935
[TBL] [Abstract][Full Text] [Related]
29. Significance of flat epithelial atypia on mammotome core needle biopsy: Should it be excised?
Kunju LP; Kleer CG
Hum Pathol; 2007 Jan; 38(1):35-41. PubMed ID: 17095049
[TBL] [Abstract][Full Text] [Related]
30. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions.
Barth PJ; Ebrahimsade S; Ramaswamy A; Moll R
Virchows Arch; 2002 Mar; 440(3):298-303. PubMed ID: 11889601
[TBL] [Abstract][Full Text] [Related]
31. Molecular alterations in columnar cell lesions of the breast.
Dabbs DJ; Carter G; Fudge M; Peng Y; Swalsky P; Finkelstein S
Mod Pathol; 2006 Mar; 19(3):344-9. PubMed ID: 16400324
[TBL] [Abstract][Full Text] [Related]
32. Pseudoangiomatous stromal hyperplasia in lesions involving anogenital mammary-like glands.
Kazakov DV; Bisceglia M; Mukensnabl P; Michal M
Am J Surg Pathol; 2005 Sep; 29(9):1243-6. PubMed ID: 16096415
[TBL] [Abstract][Full Text] [Related]
33. Lobular in situ neoplasia and columnar cell lesions: diagnosis in breast core biopsies and implications for management.
Pinder SE; Provenzano E; Reis-Filho JS
Pathology; 2007 Apr; 39(2):208-16. PubMed ID: 17454750
[TBL] [Abstract][Full Text] [Related]
34. Pseudoangiomatous stromal hyperplasia and breast cancer risk.
Degnim AC; Frost MH; Radisky DC; Anderson SS; Vierkant RA; Boughey JC; Pankratz VS; Ghosh K; Hartmann LC; Visscher DW
Ann Surg Oncol; 2010 Dec; 17(12):3269-77. PubMed ID: 20567920
[TBL] [Abstract][Full Text] [Related]
35. Breaking down barriers: the importance of the stromal microenvironment in acquiring invasiveness in young women's breast cancer.
Schedin P; Borges V
Breast Cancer Res; 2009; 11(2):102. PubMed ID: 19344495
[TBL] [Abstract][Full Text] [Related]
36. Pseudoangiomatous stromal hyperplasia: an overview.
Virk RK; Khan A
Arch Pathol Lab Med; 2010 Jul; 134(7):1070-4. PubMed ID: 20586640
[TBL] [Abstract][Full Text] [Related]
37. Low-grade ductal carcinoma in situ and invasive mammary carcinoma with columnar cell morphology arising in a complex fibroadenoma in continuity with columnar cell change and flat epithelial atypia.
Petersson F; Tan PH; Putti TC
Int J Surg Pathol; 2010 Oct; 18(5):352-7. PubMed ID: 20643672
[TBL] [Abstract][Full Text] [Related]
38. Pseudoangiomatous stromal hyperplasia of the breast: a contemporary approach to its clinical and radiologic features and ideal management.
Gresik CM; Godellas C; Aranha GV; Rajan P; Shoup M
Surgery; 2010 Oct; 148(4):752-7; discussion 757-8. PubMed ID: 20708765
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression.
Vargas AC; McCart Reed AE; Waddell N; Lane A; Reid LE; Smart CE; Cocciardi S; da Silva L; Song S; Chenevix-Trench G; Simpson PT; Lakhani SR
Breast Cancer Res Treat; 2012 Aug; 135(1):153-65. PubMed ID: 22718308
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor secreted by activated stroma enhances angiogenesis and hormone-independent growth of estrogen receptor-positive breast cancer.
Pinto MP; Badtke MM; Dudevoir ML; Harrell JC; Jacobsen BM; Horwitz KB
Cancer Res; 2010 Apr; 70(7):2655-64. PubMed ID: 20332242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
